Report Detail
Global Allergy Immunotherapies (Allergy Immunotherapy) Market Growth (Status and Outlook) 2019-2024
- RnM3035504 |
- 27 February, 2019 |
- Global |
- 115 Pages |
- LPI(LP Information) |
- Other
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
The classification of Allergy Immunotherapy includes Subcutaneous Immunotherapy and Sublingual Immunotherapy. The proportion of Subcutaneous Immunotherapy in 2017 is about 55.1%, and the proportion of Sublingual Immunotherapy in 2016 is about 44.9%.
Allergy Immunotherapy are application in Allergic Rhinitis, Allergic Asthma and Other. The most of Allergy Immunotherapy is used in Allergic Rhinitis, and the market share of that is about 45.3 % in 2017.
Europe is the largest consumption place, with a consumption market share nearly 68.5% in 2017, Allergy is the most common chronic disease in Europe. Up to 20% of patients with allergies struggle daily with the fear of a possible asthma attack, anaphylactic shock, or even death from an allergic reaction. Following Europe, North America is the second largest consumption place with the consumption market share of 19.2% in 2017. Allergy Immunotherapy market in Asia Pacific region is expected to exhibit the highest growth rate due to high incidence of allergy people in the developing Asian countries like China & India.
Market competition is intense. ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, etc. are the leaders of the industry with the market share is about 76.6% in 2017.
According to this study, over the next five years the Allergy Immunotherapies (Allergy Immunotherapy) market will register a 9.9% CAGR in terms of revenue, the global market size will reach US$ 1890 million by 2024, from US$ 1070 million in 2019. In particular, this report presents the global revenue market share of key companies in Allergy Immunotherapies (Allergy Immunotherapy) business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Allergy Immunotherapies (Allergy Immunotherapy) market by product type, application, key companies and key regions.
This study considers the Allergy Immunotherapies (Allergy Immunotherapy) value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Subcutaneous Immunotherapy
Sublingual Immunotherapy
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Allergic Rhinitis
Allergic Asthma
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
ALK-Abello
Stallergenes Greer
Merck
Allergy Therapeutics
HAL
WOLW Pharma
Holister Stier
Leti
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Allergy Immunotherapies (Allergy Immunotherapy) market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Allergy Immunotherapies (Allergy Immunotherapy) market by identifying its various subsegments.
Focuses on the key global Allergy Immunotherapies (Allergy Immunotherapy) players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Allergy Immunotherapies (Allergy Immunotherapy) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Allergy Immunotherapies (Allergy Immunotherapy) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Allergy Immunotherapies (Allergy Immunotherapy) Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Allergy Immunotherapies (Allergy Immunotherapy) Market Size 2014-2024
- 2.1.2 Allergy Immunotherapies (Allergy Immunotherapy) Market Size CAGR by Region
- 2.2 Allergy Immunotherapies (Allergy Immunotherapy) Segment by Type
- 2.2.1 Subcutaneous Immunotherapy
- 2.2.2 Sublingual Immunotherapy
- 2.3 Allergy Immunotherapies (Allergy Immunotherapy) Market Size by Type
- 2.3.1 Global Allergy Immunotherapies (Allergy Immunotherapy) Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Allergy Immunotherapies (Allergy Immunotherapy) Market Size Growth Rate by Type (2014-2019)
- 2.4 Allergy Immunotherapies (Allergy Immunotherapy) Segment by Application
- 2.4.1 Allergic Rhinitis
- 2.4.2 Allergic Asthma
- 2.4.3 Other
- 2.5 Allergy Immunotherapies (Allergy Immunotherapy) Market Size by Application
- 2.5.1 Global Allergy Immunotherapies (Allergy Immunotherapy) Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Allergy Immunotherapies (Allergy Immunotherapy) Market Size Growth Rate by Application (2014-2019)
3 Global Allergy Immunotherapies (Allergy Immunotherapy) by Players
- 3.1 Global Allergy Immunotherapies (Allergy Immunotherapy) Market Size Market Share by Players
- 3.1.1 Global Allergy Immunotherapies (Allergy Immunotherapy) Market Size by Players (2017-2019)
- 3.1.2 Global Allergy Immunotherapies (Allergy Immunotherapy) Market Size Market Share by Players (2017-2019)
- 3.2 Global Allergy Immunotherapies (Allergy Immunotherapy) Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Allergy Immunotherapies (Allergy Immunotherapy) by Regions
- 4.1 Allergy Immunotherapies (Allergy Immunotherapy) Market Size by Regions
- 4.2 Americas Allergy Immunotherapies (Allergy Immunotherapy) Market Size Growth
- 4.3 APAC Allergy Immunotherapies (Allergy Immunotherapy) Market Size Growth
- 4.4 Europe Allergy Immunotherapies (Allergy Immunotherapy) Market Size Growth
- 4.5 Middle East & Africa Allergy Immunotherapies (Allergy Immunotherapy) Market Size Growth
5 Americas
- 5.1 Americas Allergy Immunotherapies (Allergy Immunotherapy) Market Size by Countries
- 5.2 Americas Allergy Immunotherapies (Allergy Immunotherapy) Market Size by Type
- 5.3 Americas Allergy Immunotherapies (Allergy Immunotherapy) Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Allergy Immunotherapies (Allergy Immunotherapy) Market Size by Countries
- 6.2 APAC Allergy Immunotherapies (Allergy Immunotherapy) Market Size by Type
- 6.3 APAC Allergy Immunotherapies (Allergy Immunotherapy) Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Allergy Immunotherapies (Allergy Immunotherapy) by Countries
- 7.2 Europe Allergy Immunotherapies (Allergy Immunotherapy) Market Size by Type
- 7.3 Europe Allergy Immunotherapies (Allergy Immunotherapy) Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Allergy Immunotherapies (Allergy Immunotherapy) by Countries
- 8.2 Middle East & Africa Allergy Immunotherapies (Allergy Immunotherapy) Market Size by Type
- 8.3 Middle East & Africa Allergy Immunotherapies (Allergy Immunotherapy) Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Allergy Immunotherapies (Allergy Immunotherapy) Market Forecast
- 10.1 Global Allergy Immunotherapies (Allergy Immunotherapy) Market Size Forecast (2019-2024)
- 10.2 Global Allergy Immunotherapies (Allergy Immunotherapy) Forecast by Regions
- 10.2.1 Global Allergy Immunotherapies (Allergy Immunotherapy) Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Allergy Immunotherapies (Allergy Immunotherapy) Forecast by Type
- 10.8 Global Allergy Immunotherapies (Allergy Immunotherapy) Forecast by Application
11 Key Players Analysis
- 11.1 ALK-Abello
- 11.1.1 Company Details
- 11.1.2 Allergy Immunotherapies (Allergy Immunotherapy) Product Offered
- 11.1.3 ALK-Abello Allergy Immunotherapies (Allergy Immunotherapy) Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 ALK-Abello News
- 11.2 Stallergenes Greer
- 11.2.1 Company Details
- 11.2.2 Allergy Immunotherapies (Allergy Immunotherapy) Product Offered
- 11.2.3 Stallergenes Greer Allergy Immunotherapies (Allergy Immunotherapy) Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Stallergenes Greer News
- 11.3 Merck
- 11.3.1 Company Details
- 11.3.2 Allergy Immunotherapies (Allergy Immunotherapy) Product Offered
- 11.3.3 Merck Allergy Immunotherapies (Allergy Immunotherapy) Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Merck News
- 11.4 Allergy Therapeutics
- 11.4.1 Company Details
- 11.4.2 Allergy Immunotherapies (Allergy Immunotherapy) Product Offered
- 11.4.3 Allergy Therapeutics Allergy Immunotherapies (Allergy Immunotherapy) Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Allergy Therapeutics News
- 11.5 HAL
- 11.5.1 Company Details
- 11.5.2 Allergy Immunotherapies (Allergy Immunotherapy) Product Offered
- 11.5.3 HAL Allergy Immunotherapies (Allergy Immunotherapy) Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 HAL News
- 11.6 WOLW Pharma
- 11.6.1 Company Details
- 11.6.2 Allergy Immunotherapies (Allergy Immunotherapy) Product Offered
- 11.6.3 WOLW Pharma Allergy Immunotherapies (Allergy Immunotherapy) Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 WOLW Pharma News
- 11.7 Holister Stier
- 11.7.1 Company Details
- 11.7.2 Allergy Immunotherapies (Allergy Immunotherapy) Product Offered
- 11.7.3 Holister Stier Allergy Immunotherapies (Allergy Immunotherapy) Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Holister Stier News
- 11.8 Leti
- 11.8.1 Company Details
- 11.8.2 Allergy Immunotherapies (Allergy Immunotherapy) Product Offered
- 11.8.3 Leti Allergy Immunotherapies (Allergy Immunotherapy) Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Leti News
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Allergy Immunotherapies (Allergy Immunotherapy) . Industry analysis & Market Report on Allergy Immunotherapies (Allergy Immunotherapy) is a syndicated market report, published as Global Allergy Immunotherapies (Allergy Immunotherapy) Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Allergy Immunotherapies (Allergy Immunotherapy) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
